Inflamalps

Swiss biopharmaceutical company developing topical treatments for inflammation-mediated diseases in ophthalmology and dermatology

placeMonthey, Valais, Switzerland calendar_todayFounded 2012 groups140 employees language inflamalps.com

Innovation

1 patent family — focus: Human necessities; filing pace accelerating. Cited 10 times.

YearFilings
20231
20251
20261

Investor mix

3 investors on record.

Investor typeCountShare
Private equity133%
Accelerator & incubator133%
Other / undisclosed133%
Coming soon